middle.news
PainChek Accelerates Global Reach with 10% Revenue Growth in Q2
9:10am on Thursday 3rd of July, 2025 AEST
•
Healthcare
Read Story
PainChek Accelerates Global Reach with 10% Revenue Growth in Q2
9:10am on Thursday 3rd of July, 2025 AEST
Key Points
Net contracted licences rise 9% to 110,000
Annual recurring revenue grows 10% to A$5.4 million
Net licence retention rate exceeds 100%, indicating customer expansion
New contracts secured in UK, Australia, and Canada with varied terms
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE